Water-based lubricant is a personal lubricant for penile, anal and/or vaginal application, intended to moisturize and lubricate, to enhance the ease and comfort of intimate sexual activity and supplement the body’s natural lubrication. This product is compatible with natural rubber latex and polyisoprene condoms. This product is not compatible with polyurethane condoms.
Device Story
Water-based personal lubricant; applied topically to penile, anal, or vaginal areas; intended to moisturize and supplement natural lubrication during sexual activity. Enhances comfort; compatible with natural rubber latex and polyisoprene condoms. Non-sterile viscous liquid; OTC use. Benefits include reduced friction and increased comfort during intimate activity.
Clinical Evidence
No clinical data. Evidence consists of bench testing: biocompatibility (cytotoxicity, sensitization, acute systemic toxicity, vaginal irritation per ISO 10993), shelf-life (accelerated aging), and condom compatibility (ASTM D7661-23).
Indicated for individuals requiring personal lubrication for penile, anal, and/or vaginal application to moisturize, lubricate, and enhance comfort during sexual activity. Compatible with natural rubber latex and polyisoprene condoms; contraindicated for use with polyurethane condoms.
Regulatory Classification
Identification
A condom is a sheath which completely covers the penis with a closely fitting membrane. The condom is used for contraceptive and for prophylactic purposes (preventing transmission of sexually transmitted infections). The device may also be used to collect semen to aid in the diagnosis of infertility.
Special Controls
*Classification.* (1) Class II (special controls) for condoms made of materials other than natural rubber latex, including natural membrane (skin) or synthetic.(2) Class II (special controls) for natural rubber latex condoms. The guidance document entitled “Class II Special Controls Guidance Document: Labeling for Natural Rubber Latex Condoms Classified Under 21 CFR 884.5300” will serve as the special control. See § 884.1(e) for the availability of this guidance document.
K180219 — JO H2O Flavored Personal Lubricants · United Consortium · Apr 20, 2018
K172447 — JO Gelato Flavored Personal Lubricants · United Consortium · Oct 31, 2017
K200731 — pjur AQUA Baseline, pjur AQUA Guarana, pjur AQUA ProVitamin B5, pjur BACK DOOR anal Provitamin B5 · Pjur Group Luxembourg S.A. · Jan 21, 2021
K222567 — Playground For All Love Sesh · Playground For All · Jan 30, 2023
K250142 — Water-based Lubricant · Global Protection Corp. · Aug 8, 2025
Submission Summary (Full Text)
{0}
FDA U.S. FOOD & DRUG ADMINISTRATION
March 6, 2026
Guangzhou Haoyimai Trading Co., Ltd.
% Aria Yao
Regulatory Affairs Specialist
Shenzhen Joyantech Consulting Co., Ltd.
1713a, 17th Floor, Block A, Zhongguan Times Square
Liuxian Ave., Xili Town, Nanshan District
Shenzhen, Guangdong 518000
CHINA
Re: K253983
Trade/Device Name: Water-based lubricant
Regulation Number: 21 CFR 884.5300
Regulation Name: Condom
Regulatory Class: II
Product Code: NUC
Received: December 12, 2025
Dear Aria Yao:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: The Center for Devices and Radiological Health (CDRH) does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, the Food and Drug Administration (FDA) may publish further announcements concerning your device in the Federal Register.
U.S. Food & Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
www.fda.gov
{1}
K253983 - Aria Yao
Page 2
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the
{2}
K253983 - Aria Yao
Page 3
Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Monica D. Garcia -S
Monica D. Garcia, Ph.D.
Assistant Director
DHT3B: Division of Reproductive, Gynecology, and Urology Devices
OHT3: Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices
Office of Product Evaluation and Quality
Center for Devices and Radiological Health
Enclosure
{3}
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Indications for Use
Form Approved: OMB No. 0910-0120
Expiration Date: 06/30/2023
See PRA Statement below.
510(k) Number (if known)
K253983
Device Name
Water-based lubricant
Indications for Use (Describe)
Water-based lubricant is a personal lubricant for penile, anal and/or vaginal application, intended to moisturize and lubricate, to enhance the ease and comfort of intimate sexual activity and supplement the body’s natural lubrication. This product is compatible with natural rubber latex and polyisoprene condoms. This product is not compatible with polyurethane condoms.
Type of Use (Select one or both, as applicable)
☐ Prescription Use (Part 21 CFR 801 Subpart D)
☑ Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
*DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services
Food and Drug Administration
Office of Chief Information Officer
Paperwork Reduction Act (PRA) Staff
PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
FORM FDA 3881 (6/20)
Page 1 of 1
PSC Publishing Services (301) 443-6740
{4}
K253983
Page 1 of 4
# 510(k) Summary (K253983)
## 1. Date of Preparation
March 6, 2026
## 2. Submitter's Information
| Applicant Name | Guangzhou Haoyimai Trading Co., Ltd. |
| --- | --- |
| Address | 10th Floor, Building B, Shiliushe Industrial Zone, Xiamao
Shixia Road, Baiyunhu Street, Baiyun District, Guangzhou |
| Contact person | Coco Ling |
| Phone | +86 139 0847 3323 |
## 3. Device Identification
| Proprietary/Trade Name: | Water-based lubricant |
| --- | --- |
| Common Name | Personal lubricant |
| Regulation Number: | 21 CFR 884.5300 |
| Regulation Name | Condom |
| Product Code: | NUC (lubricant, personal) |
| Review Panel: | Obstetrics/Gynecology |
| Regulatory Class: | II |
## 4. Predicate Device Information
| Trade Name | ID Free® Personal Lubricant |
| --- | --- |
| 510(k) Number | K240745 |
| Product Code | NUC |
| Manufacturer | Westridge Laboratories, Inc.
The predicate device has not been subject to a design-related recall |
## 5. Device Description
Water-based lubricant is a non-sterile, water-based personal lubricant for penile, anal and/or vaginal application, intended to moisturize and lubricate, to enhance the ease and comfort of intimate sexual activity and supplement the body's natural lubrication. This product is compatible with natural rubber latex and polyisoprene condoms. This product is not compatible with polyurethane condoms.
Page 1 of 4
{5}
K253983
Page 2 of 4
Its formulation consists of purified water, 1,3-butanediol, propylene glycol, carbomer, glycerin, sodium hyaluronate, hydroxyethyl cellulose, sodium benzoate, sodium polyacrylate, citric acid, menthol, essence, and octyl hydroxamic acid.
The device specifications are listed in Table 1 below:
Table 1: Device Specifications for the Water-based lubricant
| Property | Specification |
| --- | --- |
| Appearance | Viscous liquid |
| Color | Clear |
| Odor | Odorless |
| Viscosity per USP<911> | 1-200 cPs |
| pH per USP <791> | 5.0-6.5 |
| Osmolality per USP<785> | 1-200 mOsm/kg |
| Antimicrobial effectiveness per USP<51> | Meets USP <51> acceptance criteria for Category 2 products. Category 2, bacteria should show no less than 2.0 log reduction at 14 days and no increase from the 14-day count to the 28-day count. Yeast and molds should show no increase from the initial calculated count at 14 and 28 days |
| Total aerobic microbial count (TAMC) per USP<61> and <1111> | <100CFU/g |
| Total yeast and mold count (TYMC) per USP<61> and <1111> | <10CFU/g |
| Absence of Pathogenic Organisms per USP<62> | Specification |
| Bile-Tolerant Gram negative bacteria | Absent |
| Staphylococcus aureus | Absent |
| Salmonella spp. | Absent |
| Escherichia coli | Absent |
| Pseudomonas aeruginosa | Absent |
| Clostridia | Absent |
| Candida albicans | Absent |
## 6. Indications for Use
Water-based lubricant is a personal lubricant for penile, anal and/or vaginal application, intended to moisturize and lubricate, to enhance the ease and comfort of intimate sexual activity and supplement the body's natural lubrication. This product is compatible with natural rubber latex and polyisoprene condoms. This product is not compatible with polyurethane condoms.
## 7. Comparison of Intended Use and Technological Characteristics of the Subject and Predicate Device
The below table compares the intended use and technological characteristics of the subject and predicate device.
Page 2 of 4
{6}
K253983
Page 3 of 4
| Comparison item | Subject Device: Water-based lubricant | Predicate Device: ID Free® Personal Lubricant (K240745) | Comments |
| --- | --- | --- | --- |
| Product Code | NUC | NUC | Same |
| Indications for Use | Water-based lubricant is a personal lubricant for penile, anal and/or vaginal application, intended to moisturize and lubricate, to enhance the ease and comfort of intimate sexual activity and supplement the body's natural lubrication. This product is compatible with natural rubber latex and polyisoprene condoms. This product is not compatible with polyurethane condoms. | ID Free® Personal Lubricant is a personal lubricant, for penile, anal and/or vaginal application intended to moisturize and lubricate, to enhance the ease and comfort of intimate sexual activity and supplement the body's natural lubrication. This product is compatible with natural rubber latex and polyisoprene condoms. This product is not compatible with polyurethane condoms. | Same |
| Water soluble | Yes | Yes | Same |
| Primary ingredients | Purified water, 1,3-butanediol, propylene glycol, carbomer, glycerin, sodium hyaluronate, hydroxyethyl cellulose, sodium benzoate, sodium polyacrylate, citric acid, menthol, essence, octyl hydroxamic acid | Water, Propanediol, Hydroxyethylcellulose, Carbomer, PEG 45M, EDTA, Tetrahydroxypropyl Ethylenediamine, Caprylhydroxamic acid, Sucrose | Different |
| pH | 5.0-6.5 | 5.0 - 5.5 | Different |
| Osmolality (mOsm/kg) | 1-200 | 250 - 500 | Different |
| Viscosity (mPa.s) | 1-200 | 2,200 - 4,400 | Different |
| Over the counter use | Yes | Yes | Same |
| Sterile | No | No | Same |
| Condom Compatibility | Latex, Polyisoprene | Latex, Polyisoprene | Same |
| Biocompatibility Test | Cytotoxicity (ISO 10993-5)
Sensitization (ISO 10993-10)
Acute Systemic Toxicity (ISO 10993-11)
Vaginal Irritation (ISO 10993-23) | Cytotoxicity (ISO 10993-5)
Sensitization (ISO 10993-10)
Acute Systemic Toxicity (ISO 10993-11)
Vaginal Irritation (ISO 10993-10) | Same |
| Antimicrobial Tested | Yes | Yes | Same |
| Shelf life | 3 years | 2 years | Different |
Page 3 of 4
{7}
K253983
Page 4 of 4
The subject device and predicate device have the same intended use. The subject and predicate devices differ in ingredients, specifications (e.g., pH, osmolality, and viscosity), and shelf-life. These differences do not raise different questions of safety and effectiveness and can be evaluated through performance testing.
## 8. Summary of Non-Clinical Testing
### *Biocompatibility
Biocompatibility testing was performed in accordance with the 2023 FDA guidance document “Use of International Standard ISO 10993-1, “Biological Evaluation of Medical Devices – Part 1: Evaluation and testing within a risk management process”, as follows:
- In Vitro Cytotoxicity Test, per ISO 10993-5:2009
- Skin Sensitization Test, per ISO 10993-10:2021
- Acute Systemic Toxicity Test, per ISO 10993-11:2017
- Vaginal Irritation Test, per ISO 10993-23:2021
The results of this testing demonstrated that the subject lubricant is non-cytotoxic, non-irritating, non-sensitizing, and not systemically toxic.
### *Shelf Life
The subject device is a non-sterile personal lubricant with a 3 years shelf life based on the results of accelerated aging studies. Testing on the samples demonstrated that the subject device met all device specifications listed in Table 1 above across the device shelf-life.
### *Condom Compatibility
The compatibility of the subject device with condoms was evaluated in accordance with ASTM D7661-23, Standard Test Method for Determining Compatibility of Personal Lubricants with Natural Rubber Latex Condoms. The results of this testing indicate that the subject device is compatible with natural rubber latex and polyisoprene condoms, is not compatible with polyurethane condoms.
## 9. Conclusion
The results of the performance testing described above demonstrate that Water-based lubricant is as safe and effective as the predicate device and supports a determination of substantial equivalence.
Page 4 of 4
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.
Sort by:
Create Alert
Search Filters
Agent Token
Create a read-only bearer token for Claude, ChatGPT, or other agents that can call HTTP APIs.